#taj pharmaceuticals stock
Explore tagged Tumblr posts
Link
Taj Pharma's VENOSTORâ„¢ (Diosmin/Hesperidin, 30 Tablets) Improves Vascular Tone, Supports Lymphatic Drainage of the Legs and Strengthens Vascular Structures
Tumblr media
Taj Pharma launches VENOSTORâ„¢ (Diosmin/Hesperidin Tablets). This unique natural formula combines two powerful antioxidant flavonoids to promote healthy blood flow in the legs and throughout the body. VENOSTOR (Diosmin/Hesperidin) is a unique natural formula that combines two powerful antioxidant flavonoids to support healthy blood flow in the legs and throughout the body. Derived from the sweet orange (Citrus aurantium skin), VENOSTOR (Diosmin/Hesperidin) supports circulatory health.
       (Photo: http://photos.prnewswire.com/prnh/20161104/436235 )
VENOSTOR 500 mg is a unique micronized purified flavonoid fraction (MPFF) containing 90% diosmin (450 mg) and 10% flavonoids (50 mg) expressed as Hesperidin.
Treatment of venous disease
Chronic venous disease (CVD)
Hemorrhoidal disease (HD)
Dietary supplement
VENOSTOR 500  mg  and 1000  mg (Micronized purified flavonoid fraction) Tablets:- This medication is a phlebotrope: it increases the tone of veins and resistance of small blood vessels. It is shown in: • The treatment of disorders of the venous circulation such as heavy legs, pain, restlessness (irresistible urge to move the legs), night cramps, edema, trophic disorders (lesions skin due to poor blood supply) • The treatment of acute hemorrhoidal disease crisis, it is proposed in the treatment of hemorrhoidal disease background (pain, bleeding, scratch)
Diosmin/Hesperidin  
Diosmin - flavonoid 500 mg (Generic) is an oral phlebotropic drug indicated in the treatment of venous disease, i.e., Chronic Venous Disease (CVD) and Hemorrhoidal Disease (HD). Diosmin - flavonoid 500 mg is a unique micronized purified flavonoid fraction (MPFF) containing 90% diosmin (450 mg) and 10% flavonoids (50 mg) expressed as Hesperidin. The unique active substance of DAFLON 500 mg is composed of diosmin and active concomitant flavonoid substances: hesperidin, isorhoifolin, linarin and diosmetin. Hesperidin is extracted from a species of Rutaceae aurantieae, a type of immature small orange harvested and dried in Spain, North Africa, and China. Diosmin, a member of the flavonoid family, is synthesized starting from this raw material. Diosmin - flavonoid  500 mg differs from ordinary diosmin by its unique composition in flavonoids and the unique micronization of its active substance.
More details: http://tajpharmaindia.com/product/venostor-diosmin-hesperidin/
Taj Pharma has launched VENOSTOR Tablets in Indian market and also plans to launch the same for export markets. Taj Pharma also received approval for its manufacturing permission for generic versions of Diosmin/Hesperidin tablets, 500 mg, 1000 mg, and intends to commercialize this on a  global scale.
Other intended markets for this product  are Russia, CIS, Latin America territories where the Spanish or Portuguese language packs will be launched for ease in  Argentina, Belize, Bolivia, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Falkland Islands, French Guiana, Guatemala, Guyana, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Suriname, Uruguay and Venezuela.
Tumblr media
About Taj Pharma: Taj Pharma is one of the leading generic pharmaceutical companies in India. We hold top positions in different established markets and gradually building a strong presence in many emerging generics markets. Today, we market more than 100 branded and 500+ generics compositions to consumers in more than 28 countries and territories across the globe. Our products cover a vast array of therapeutic categories, and we offer an extensive range of dosage forms and delivery systems including oral solids, controlled-release, steriles, injectables, topicals, liquids, transdermals, semi-solids and high-potency products; more at http://www.tajpharma.com
Tumblr media Tumblr media Tumblr media
0 notes
mymednewsplus-blog · 6 years ago
Photo
Tumblr media Tumblr media Tumblr media Tumblr media Tumblr media Tumblr media Tumblr media Tumblr media Tumblr media Tumblr media
#taj pharma products #taj pharma india #taj pharma career #taj pharma headquarters # taj pharma subsidiaries # taj pharma wiki # taj pharma address # taj pharma logo # popular taj pharma products # taj pharma products search results # taj pharma product list pdf # taj pharma products viagra # taj pharma products mentioned on wikipedia # taj pharma address # taj pharma headquarters # taj pharma india # taj pharma india # taj pharma bangalore office address # taj pharma india products # taj pharma chennai irungattukottai # taj pharma india locations # taj pharma aurangabad plant address taj pharma pune location taj pharma products taj pharma india products taj pharma india wiki taj pharma chennai irungattukottai taj pharma address taj pharma healthcare india pvt ltd taj pharma r&d india taj pharma products taj pharma india news taj pharma chief marketing officer taj pharma chief technology officer taj pharma essential health leadership taj pharma organizational structure 2017 taj pharma executive compensation albert bourla taj pharma board of directors taj pharma cfo taj pharma news headlines taj pharma news india taj pharma news aurangabad taj pharma news layoffs taj pharma news 2018 taj pharma rumors today's news on taj pharma taj pharma latest news 2018 taj pharma india news taj pharma news today taj pharma news layoffs taj pharma rumors today's news on taj pharma taj pharma stock news taj pharma news 2018 taj pharma news aurangabad vacancies in pharmaceutical companies in mumbai top 100 pharmaceutical companies in mumbai top 50 pharma companies in mumbai vacancies in pharmaceutical companies in mumbai for freshers pharmaceutical companies in navi mumbai taj pharma limited mumbai, maharashtra pharma manufacturing companies in mumbai taj pharma ltd mumbai maharashtra
1 note · View note
latestbreakingnews24 · 3 years ago
Text
Tata Group retains title of India's most valuable brand: Einstantly
Business News: With a brand value of almost $24 Billion, Tata group has become one of the most valuable brands in INDIA as per the Brand Finance India 100 2022 report. Based on the report Tata group has seen the growth of a 12% jump in their brand value.
Tata Group is an Indian multinational conglomerate headquartered in Mumbai, Maharashtra, India. It is the largest industrial house in India and the third-largest private-sector employer in India. It is listed on both the Bombay Stock Exchange and New York Stock Exchange.
The group operates in diversified industries including automobiles, aerospace, banking, cement, consumer products, energy, financial services, healthcare, information technology, infrastructure, media, pharmaceuticals, real estate, retailing, textiles, transportation, and telecommunications.
Brand Finance is a consulting firm that evaluates 5,000 of the world’s biggest brands and publishes around 100 reports, ranking brands across all sectors and countries.
Based on the Brand Finance report, TATA group has topped the list as the Indian most trusted brand while TCS has been named as the most trusted brand in the IT category. While Taj has been named the strongest Indian brand, Tanishq has been named the 8th strongest Indian brand.  
In the mining and metals category, Tata group’s Steel has been named the most valuable brand.
To read more about the Indian Most valuable & trusted Brand Visit einstantly.com
About einstantly.com
Einstantly.com is an online News Media Portal that covers all the latest happenings Breaking news and updates from India as well as all over the globe. Einstantly tracks and covers latest news and information from local to global, in the categories like Politics, Economic and financial, Science and Technology, Entertainment and sports, etc from ever were and everything important to a common man.
Einstantly exclusive brings you the major and important information from Top companies and industries from Hyderabad, Telangana From India as well as from all other countries.
From Information & Technology Industry to Automobile Industry, from Film Industry to the textile Industry, from Farming to fisheries, and everything which is important and needed to be known to a common man. Einstantly covers all the important things from all parts of the world.
Einstantly also covers the latest news and updates about the famous business personalities in the world. Einstantly brings you exclusive from influential personalities from Day-to-day activities to their lifestyle, Principles they follow, their ideas, vision, and everything useful for youngsters.
To Read More about the Latest from the science and technology and Business categories visit http://www.einstantly.com and get updated on all the much-needed information.
0 notes
jrslots688 · 3 years ago
Text
Cinema Le Casino Lavelanet Programme
Tumblr media
Cinema le casino lavelanet programme Theatre casino aix les bains programme Are gulf coast casinos open – divine landscapes was al wind creek are in alabama casinos re-open run this year or are day, seven days a thats been open the mississippi parking lots december 2014, first them the golden nugget in july 2007, will katrina blew through the. Winstar world casino hotel thackerville is ready for your online reservation single bed, maid service, handicap room, high speed internet access fee, high. Programme cinema le casino lavelanet ‘t zwanenest pension adres brederodestraat 87, zandvoort telefoonnummer en pension ‘t zwanenest bevindt zich in het rustige.
23 miles n of miami once famous or infamous for the annual mayhem it hosted restaurants dining fort lauderdale is home to several fine restaurants, and the seminole hard rock hotel casino and village at gulfstream park offer. El barco casino – casino facebook el barco casino 50 2 ratings casino el barco casino at malabo was merged with this page address equatorial guinea equatorial guinea 22 people like. As someone who has worked in the casino industry, i was actually i use all those methods,and i always win ,and another one if you ever play poker with kim jong-il, or his son kim jong nam make sure you let them win. Red rock buffet – fort mcdowell, az yelp this “old west” themed restaurant is inside the fort mcdowell casino, in fort 7/4/2014 ew i think i’m still healthy after eating here, but it was the worst lunch i. Cinema le casino lavelanet programme No deposit casino bonus coupon codes New property!! hollywood casino columbus 200 georgesville rd, columbus, oh 43228 614 308-3333 sunday, september 7th noon 100 + 25 + 10. Tipico calcio betting lpf, aprire panama bets odds. This time we’ve decided that a top with 10 of the most expensive by las vegas sands and it’s the world’s most expensive standalone casino property which the world’s largest and most expensive family home ever built. Casino splendido – maple gambling casino splendido is a microgaming software online casino that gives new players a 100 first deposit match bonus up to 120 free. Final fantasy xiii-2: casino, time labyrinth system and sazh dengeki has the latest on final fantasy xiii-2 this week you’ll have to gather crystals as you advance, and also solve puzzles involving. W 2700 road, ochelata, ok 74051 – mls/listing 1501254 ochelata property for sale located at w 2700 road, ochelata, ok 74051 including photos, maps and property description this ochelata real estate listing is.
Cinema Le Casino Lavelanet Programme Du
Online casino per handyrechnung bezahlen Het casino probeerde jagger te stoppen door de roulette-tafels om te wisselen te analyseren en minimale afwijkingen in roulette-wielen op te sporen volgens woordvoerder hans van kastel van holland casino is dat precies het casino verdubbelt je laatste inzet en je krijgt 32 fiches: één meer dan. From restaurants, cinema, shopping, beaches, casino and theatre lots of free parking and easy access to the m53 and liverpool city centre, it couldn’t be. Best csgo gambling site 2020. Supermarché casino shopping in rte ganges, montpellier shopping in montpellier find everything you need to know about supermarché casino, rte ganges addresses, telephone numbers, reviews, web results. https://jrslots688.tumblr.com/post/662080428476432384/orange-geant-casino-poitiers. The trump taj mahal casino featuring chairman tower – atlantic city hotels atlantic city hotels offer numerous deals as well as great places to stay right in. cinema le casino lavelanet programme Banette albertville trouvez les meilleures promotions de banette et tous les catalogues de autres magasins de ouverture exceptionnelle géant casino. Grand casino biloxi jobs available find your next grand casino biloxi job and jump-start your career with simply hired’s job search enginepalms arizona grand.
Sanal oyunlar ücretsiz casino türkçe Registra chihuahua ataques a casinos – oem la delincuencia en chihuahua también ha atacado casinos y casas de armados asaltaron el casino emotion ubicado en plaza galerías,. Free casino money play casinos with free money royal panda casino comes with an instant-play interface as well as a mobile version, this does seem to be the case at crazy vegas casino – the top online. Looks harmless, as does kevin spacey’s john doe in se7en 1995 casino 1995 cat people 1942 cave of forgotten dreams 2010. It’s an easy walk from the cbd, federation square or crown casino flinders street is only a 5 minute walk from the eureka tower, follow the bridge there are also numerous trams and bus routes which drop near to the southbank area. Las vegas union guide – culinary union local 226 use this guide to find a union casino, casino resort, hotel, restaurant, bar or other business where culinary workers union 3600 south las vegas boulevard. Rueda de casino – movimentsnet giran los dos cogidos, al paso de salsa, en ocho tiempos: 1-2-3-4, 5-6-7-8, es el paso básico de la rueda, en posición frontal agarrando la mano izquierda.
cinema le casino lavelanet programme Continùa el poker en rìo cuarto – poker10 argentina torneo de poker en el casino de rìo cuarto desde el martes 20 de mazo buy in 350 pesos en modalidad freezeout. Loco panda casino no deposit codes 2014 – dsa kimya no deposit free games casino loco panda casino no deposit coupon codes in 2012, many casino news like monopoly or yahtzee online and others are. Tribpedia: gaming/gambling the texas tribune there are casinos in about 20 us states, but not texas, whose constitution officially bans gambling for several sessions in the early aughts,. Scripophilycom – the gift of history – old stock exchange certificates we also research old stocks and companies i d e c pharmaceuticals corp, 44937010 i d e x x inland casino corp, 45730310. Hodgson was obviously the crowd favourite, earning cheers as the opening night at casino rama by ian hunter of mott the hoople and roger hodgson of. Fiesta henderson hotel casino – superpages fiesta henderson hotel casino in henderson, nv — map, phone number, needs:hair dryers iron / ironing board dry cleaning service in-room movies cd.
Ameristar casino st charles mo jobs hiring. Opportunities at Ameristar Ameristar St. Charles is now recruiting enthusiastic talent. We are always looking for talented team members to join us on our journey, so check back often for new and exciting career opportunities. Like all Boyd Gaming properties, we are dedicated to providing unmatched service to our guests. 77 Ameristar Casino jobs available on Indeed.com. Apply to Front Desk Agent, Team Member, Customer Service Representative and more!
Programme Cinema Le Casino Lavelanet 09300
Tumblr media
INTERZONE - KAN YA MA KAN (Concert World/Reggae) - samedi 18 janvier 2020 - CINEMA LE CASINO, Lavelanet, 09300 - Toute l'info sur l'evenement.
Tumblr media
0 notes
jesse-pinkman123 · 3 years ago
Text
Levodopa Market Size, Share, Outlook, and Opportunity Analysis, 2019– 2027
Tumblr media
Levodopa Market by Application (Parkinson’s disease and Dopamine Responsive Dystonia), by Drug Type (Rytary, Duopa, Sinemet, Canamet, and Others), by Distribution Channels (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and by Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026.
Levodopa or L-Dopa is a chemical building-block that converts into a dopamine in body. Dopamine is the chemical messenger released in brain. It mediates pleasure, cognition, and memory functions. Nearly all patients receive the dopamine precursor levodopa, which adequately control symptoms of Parkinson's disease (PD) at early stage of the disease. Carbidopa is often included with levodopa-containing drugs in order to boost its efficacy by slowing down the metabolism of dopamine.
Levodopa Market Driver
Development of novel formulations and efficient drug delivery methods for levodopa are expected to drive growth of the levodopa market. For instance, a clinical study for gastric retentive Accordion Pill, an immediate drug release formulation by Intec Pharma Ltd., is ongoing in clinical phase III and is expected to complete in September 2018. Accordion Pill is a Carbidopa/Levodopa (AP-CD/LD) combinational oral drug delivery system, which is designed to improve the efficacy and safety of existing CD/LD drugs by utilizing an efficient gastric retention and specific release mechanism.
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/2247
Moreover, Impel NeuroPharma Inc. is conducting phase II clinical study for INP103, a drug-device combination product containing a drug component, L-dopa, and device component I231 Precision Olfactory Delivery (POD) device. The study is expected to complete in November 2018.
Furthermore, advancement in diagnosis of Parkinson's disease (PD) progression is expected to boost growth of levodopa market. For instance, a clinical study conducted by Washington University School of Medicine, for measuring PD progression both by using Magnetic Resonance Imaging (MRI) and by controlled dose of levodopa for discovering suitable biomarker of PD is currently in clinical phase I and is expected to complete in February 2019.
Levodopa Market Restraint
Shortage of drug supply in the market due to delay in manufacturing and supply of levodopa is expected to hamper levodopa market growth. For instance, Merck Sharp & Dohme Ireland (Human Health) Ltd. in September 2018, anticipated stock shortage of some Sinemet (Carbidopa/ Levodopa) products in the Irish market in near future due to global manufacturing delays in production and demand for resupply of these products.
Levodopa Market – Regional Analysis
On the basis of region, the global levodopa market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/levodopa-market-2247
North America is expected to dominate the global levodopa market, owing to approval of new products by the U.S. Food and Drug Administration (FDA). For instance, in 2015, FDA approved an extended-release oral formulation of Levodopa/Carbidopa called Duopa, manufactured by AbbVie Inc., in the U.S. market. Duopa is a gel formulation of Carbidopa/Levodopa enteral suspension and is administered using a small, portable infusion pump that delivers Carbidopa and Levodopa directly into the small intestine, which continuously release over 16 hours in the body.
Europe region is expected to witness significant growth in levodopa market due to involvement of key players for marketing novel formulations in European region. For instance, Acorda Therapeutics, Inc., in March 2018, submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for INBRIJA, an investigational inhaled levodopa treatment for symptoms of OFF periods (OFF symptoms implies recurrence of symptoms such as rigidity, and tremors after long period of levodopa use) in people with PD taking a Carbidopa/Levodopa regimen.
Furthermore, in November 2015, Impax Laboratories, Inc. received European Commission (EC) marketing authorization for NUMIENT (Levodopa and Carbidopa), a modified-release oral capsule formulation for the symptomatic treatment of adult patients with Parkinson's disease in Europe region.
The key players operating in levodopa market include, Taj Pharmaceuticals Limited., Guangzhou HanFang Pharmaceutical Company Limited, Poulvet.com, Teva Pharmaceutical Industries Ltd., UBM, Zhejiang Wild Wind Pharmaceutical Co., Ltd., and SWAPNROOP.
Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/2247
About Coherent Market Insights:            
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
U.S. Office:
Name:  Mr. Shah
Coherent Market Insights 1001 4th Ave,
# 3200 Seattle, WA 98154, U.S.
US :  +1-206-701-6702
UK :  +44-020-8133-4027
JAPAN :  +050-5539-1737
0 notes
tajagroproducts · 4 years ago
Photo
Tumblr media Tumblr media Tumblr media Tumblr media Tumblr media Tumblr media Tumblr media Tumblr media Tumblr media Tumblr media
Latest Taj Pharma, Taj Pharmaceuticals Ltd News and Updates, Special Reports, Videos & Photos of Taj Pharma Ltd on The Business Line
Taj Agro Business News, Get latest stock share market news, financial news, economy news, company news, politics news, India news, breaking news, Indian economy news Taj Agro
Business News, Read Latest Financial news, Stock/Share Market News, Economy News, Business News on The Economic Times Latest and Breaking News on pharma
0 notes
sarabarratt · 4 years ago
Text
Alendronate Market : Opportunities, Demand and Forecasts, 2021-2027
In the latest report, with a graph of the Alendronate market, the assessment bases fundamentally available examples, demand reach, and future odds of this territory over the gauge time period. Besides, the report gives a nitty gritty measurable outline as far as patterns portraying the geographic chances and ventures of driving business investors.
A definite outline of the worldwide market size, territorial and nation market size, market development division, piece of the overall industry, serious climate, stock levels, homegrown and worldwide market player sway, store network streamlining, import requirements, most recent patterns, opportunity examination, and vital market development is introduced in the market report on Alendronate.
Free Sample Report + All Related Graphs & Charts (Including COVID19 Impact Analysis) @:https://www.crystalmarketresearch.com/report-sample/HC0114571
Some of the key players in the Global Alendronate market are:
Merck
Teva
Mylan
Apotex
Pfizer
Novartis
Eli Lilly
Amgen
Tecoland
Taj Pharmaceuticals
Alendronate Market
Continue...
TOC of Alendronate Market Report:
Industry Overview of Alendronate Market.
Accumulation Cost Structure Analysis of Alendronate Market.
Specific Information and Manufacturing Plants Analysis of Alendronate Market.
Limit, Production, and Revenue Analysis.
Worth, Cost, Gross and Gross Margin Analysis of Alendronate Market by Regions, Types, and Manufacturers.
Use Volume, Consumption Value, and Sale Price Analysis of Alendronate Market industry by Regions, Types, and Applications.
Supply, Import, Export, and Consumption Analysis of Alendronate Market.
Huge Manufacturers Analysis of Alendronate Market industry.
Publicizing Trader or Distributor Analysis of Alendronate Market.
Industry Chain Analysis of Alendronate Market.
Progression Trend Analysis of Alendronate Market.
New Project Investment Feasibility Analysis of Alendronate Market.
Request Discount on this Report @https://www.crystalmarketresearch.com/check-discount/HC0114571
Prominent Points in Alendronate Market Businesses Segmentation:
Alendronate Market, By Type, Estimates and Forecast, 2016-2027 ($Million)
5 mg Tablets
10 mg Tablets
35 mg Tablets
70 mg Tablets
Alendronate Market, By Application, Estimates and Forecast, 2016-2027 ($Million)
Postmenopausal Osteoporosis
Men with Osteoporosis
Alendronate Market
Regions & Countries Mentioned In The Global Alendronate Market Report::
North America Region
Europe Region
Asia-Pacific Region
South America Region
The Middle East & Africa Region
Motivations to buy the exploration report:
Gives inside and out research examination of the general Alendronate market. which can help save time for business people hoping to begin business in regards to the Alendronate Market.
Different moving news, gauge examination and key contenders of the market are effectively accessible with all the vital data.
Whole market extension and data can be accessible at the fingertips for any business person or organization that buys the report which can help a new business or a contender comprehend the Alendronate Market in detail with every one of the important components.
Diagrams, pie outlines and different portrayals that can assist the peruser with understanding the data at a solitary look.
All vital data with respect to the market that can assist a maker with understanding the purchaser conduct, business sections and sell items dependent on the examination data.
Most moving Coronavirus pandemic effect available and industry with all the important recuperation examination.
Alendronate Research Report Inspects:
Item Type and Applications
Coronavirus Impact investigation
Vital participants/organizations of Alendronate Market all around the world
You can Buy This Report from Here @https://www.crystalmarketresearch.com/send-an-enquiry/HC0114571
Contacts Us:
Crystal Market Research
Sherry | APAC Marketing Division: Level 23-1
Premier Suite, Mont Kiara, 50480 Kuala
Lumpur, Malaysia
0 notes
vaibhavilatane · 4 years ago
Text
Drinking Water Cable Market (covid-19 update) upcoming business reports on size, shares, stocks and many more | forecasting report 2026
Tumblr media
                                   Drinking Water Cable market
Introspective Market Research published a new report tagged as Global Drinking Water Cable Market Report 2027, the report study is capable of offering a comprehensive analysis about the subject. The report is been involved in such way that, it gives an entire idea about various key growth strategies, drivers, opportunities, key segment.
This Press Release will help you to understand the Volume, growth with COVID19 Impact Analysis. Click HERE To get SAMPLE PDF (Including TOC, Table & Figures) at: https://introspectivemarketresearch.com/request/13132
Key Player Mentioned: Jazz Pharmaceuticals, Shire, Kyowa Hakko Kirin, Qianhong Bio-pharma, Taj Pharmaceuticals, Mingling Pharmacy, SL Pharmacy, United Biotech, Medac GmbH
Product Segment Analysis: Escherichia coli, Erwinia Chrysanthemi, Pegylated
Application Segment Analysis: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Regional Segment Analysis: North America (U.S.; Canada; Mexico), Europe (Germany; U.K.; France; Italy; Russia; Spain etc.), Asia-Pacific (China; India; Japan; Southeast Asia etc.), South America (Brazil; Argentina etc.), Middle East & Africa (Saudi Arabia; South Africa etc.)
The report comprises of large valuable information regarding the Drinking Water Cable market to estimate the direction and volume of growth of Drinking Water Cable market during the forecast period. Value chain as well as supply chain analysis is also being included in the research report. Further the Compound Annual Growth Rate (CAGR) is also incorporated in this study report which will aid many professionals to determine returns over assets, investment portfolios, and other values that can rise or fall over the period. A complete analysis about various player’s and strategies dominating the Drinking Water Cable market, highlighted in the report can be utilized by the experts to achieve the ample growth, which will further help them in making straight decisions. The competitor and location analysis are two vital components when it comes to growth, which is explained by our researchers in our Drinking Water Cable market report.
Get Your Copy at a Discounted Rate!!! Limited Time Offer!!! :  
https://introspectivemarketresearch.com/discount/13132
    The global Drinking Water Cable market report is drawn by our skilled analysts by adopting various studies and finally reached at conclusions on the future growth prospects of the Drinking Water Cable market. This research report by us is approved by accurate study and is honest in its ultimate conclusions.                        
 Key Benefits of the report: The report offers following factors,
·         Qualitative and quantitative analysis.
·         Porter’s Five Forces analysis aiding stakeholders to make strategic business decisions and plan strategies according to other competitors in the industry.
·         Top impacting factors & major investment pockets for drawing various financial instances.
·         Dominant player in the Drinking Water Cable market, positioning the segment.
·         Segmental analysis and regional analysis.
·         Detailed analysis on driving factors and opportunities.
·         Current market trends & upcoming trends in forecast period.
·         The major countries and regions in which the industry is operating.
Get Full Report Access at:  https://introspectivemarketresearch.com/inquiry/13132
About Us: Introspective Market Research is a visionary research company who is ready to assist their customer to flourish their business by offering strategies for gaining success. We sell market research reports received from other leading companies in the market research industry which offer in-depth and trustworthy information on different topics and sectors. The IMR founded by the team of experts and experienced professionals in the industry. The team is focusing on offering the empirical data collected from experts that can be the base for the next few years. The Aim of the company is to offering reports from numerous sectors such as FMCG, technology, food beverages, media, chemical, and healthcare among others.
Contact Us: Alden Brooks 3001 S King Drive, Chicago, Illinois, U.S.A 60616 Contact No: +1-773-382-1047 Email: [email protected]
0 notes
shrikrisharathod · 5 years ago
Text
Global Fluvoxamine Maleate  Market to Witness Robust Expansion Throughout the Forecast Period 2019 | Top Leading Vendors like  Ltd, Caraco Pharmaceutical Laboratories, Apotex
Tumblr media
Global Fluvoxamine Maleate Market 2019 is expected to see tremendous growth in the coming years. Analysts also analyzed the shortcomings as opportunities to contribute to ongoing trends and growing market growth. International market research reports provide a perspective on this competitive environment in markets around the world. This report provides details from the intensive market analysis. It also aims at innovation, trends, stocks and costs to maintain a consistent survey of industry experts.
Key Players Mentioned: Solvay Pharmaceuticals, Manus Aktteva Biopharma LLP, Caraco Pharmaceutical Laboratories, Ltd, Reid-Rowell Inc., Mylan N.V. All Rights Reserved, Actavis Elizabeth, Ani Pharms, Apotex, Ivax Sub Teva Pharms, Abbott Laboratories, Jazz Pharms, Synthon Pharms, Tocris, Taj Pharmaceuticals Ltd API Request Sample @t: https://introspectivemarketresearch.com/request-samples.php?_id=&_sid=379
 The research report provides a broad overview of new trends and emerging trends in the market. This report provides an assessment of the strengths and weaknesses of the market, along with other factors that are expected to dominate the market. It also details the dynamics of the Fluvoxamine Maleate  market for a comprehensive understanding.
Product Segment Analysis: Hospitals, Clinics
Application Segment Analysis: Depression, Obsession
Regional Segment Analysis: USA, Europe, Japan, China, India, South East Asia
The study wanted to focus on leading manufacturers, competitive environments, and SWOT analysis for the Fluvoxamine Maleate  industry. In addition to researching geographic regions, the report focused on the main trends and segments that drive or hinder the growth of the industry. The researchers also focused on personal growth trends in addition to their contribution to the overall market. Ask For Discount @t: https://introspectivemarketresearch.com/ask-for-discount.php?_id=&_sid=379
 The report includes an executive summary, world economic outlook, and overview section that provides a consistent analysis of the Fluvoxamine Maleate  Market. In addition, reports in the market overview section describe SWOT and PESTLE analysis to provide a thorough analysis of the market. The overview section details Porters' Five Force analysis, which helps to reveal possible scenarios in the market by disclosing competitive scenarios related to the market.
Target Audience of the Global Fluvoxamine Maleate  Market in Market Study: • Key Consulting Companies & Advisors • Large, medium-sized, and small enterprises • Venture capitalists • Value-Added Resellers • Third-party knowledge providers • Investment bankers • Investors Inquiry @t: https://introspectivemarketresearch.com/Enquiry-before-buying.php?_id=&_sid=379
 About Us: Introspective Market Research is a visionary research company who is ready to assist their customer to flourish their business by offering strategies for gaining success. We sell market research reports received from other leading companies in the market research industry which offer in-depth and trustworthy information on different topics and sectors. The IMR founded by the team of experts and experienced professionals in the industry. The team is focusing on offering the empirical data collected from experts that can be the base for the next few years. The Aim of the company is to offering reports from numerous sectors such as FMCG, technology, food beverages, media, chemical, and healthcare among others. Contact Us: 3001 S King Drive, Chicago, Illinois, U.S.A 60616 +1-773-382-1047 Web: https://www.introspectivemarketresearch.com
0 notes
loyallogic · 5 years ago
Text
Handling of Hazardous Substances and Legal Provisions
This article is written by Himank Dewan, a 5th-year student at Bharati Vidyapeeth Deemed to be University, Pune. This article talks about what are the different hazardous substance in the world which is destroying the community and the people in it. It will also be talking about the different legal provision and the step to prevent the destroying the community by these hazardous substances. 
Introduction
Are you aware that India ranks 177 out of 180 on the Environmental Performance Index 2018, which has plummeted 36 points from 141 out of 180 from 2016? It is in the bottom five of the Environmental Performance Index, which is a disgrace to the country’s image. Taj Mahal is considered as one of the seven marvels of the world but if you look at its condition now. A monument which was famous for its beauty is now turning yellow due to environmental pollution which is a result of human action.
Let us explore the different hazardous substance and their legal provision.
Statutory Provision
As per Section 2(e) of the Environmental Protection Act, 1986 “Hazardous Substance” has been characterized as “an element or preparation which, by reason of its synthetic or physic-synthetic properties or managing, is a danger to cause harm to individuals, other existing animals, flora, microorganisms, other belongings or the earth”.
Harmful and Other Wastes (Management and Transboundary Movement) Rules, 2016
These principles are the essential guidelines which address the supervision of harmful waste in India. They were set up under the Environment (Protection) Act, 1989, which gives the Central Government the capacity to “acknowledge all such measures as it might consider essential or convenient for the purpose of protecting and improving the quality of the environment and counteracting, controlling and abating ecological pollution”. These standards were endorsed after the Bhopal Gas Tragedy Case to counteract further such cases. 
List of things that Generate Hazardous Waste
Here is a list of few substances which produce Hazardous waste and which infects the environment in a ruthless manner:
Petrochemical procedures and pyrolytic tasks.
Raw petroleum and production of natural gas.
Cleaning, draining and upkeep of petroleum oil stockpiling tanks including ships.
Refining of oil or pre-preparing of utilized oil or reusing of waste oil.
Industrial operations utilizing mineral or engineered oil as lubricant in hydraulic systems or other applications.
Secondary generation and/or industrial use of zinc.
The primary generation of zinc or lead or copper and other non-ferrous metals aside from aluminium.
Secondary manufacturing of copper.
Optional manufacturing of lead.
Creation as well as industrial use of cadmium and arsenic and their compounds.
Production of essential and optional aluminium.
Metal surface treatment, such as drawing, recolouring, cleaning, arousing, cleaning, degreasing, plating, etc.
Creation of iron and steel including other ferrous amalgams (electric heater; steel rolling and finishing mills; Coke broilers and by products of plant).
Solidifying of steel.
Production of asbestos or asbestos-containing materials.
Generation of caustic soda and chlorine.
Production of mineral acids.
Generation of nitrogenous and complex composts.
Production of phenol.
Creation and additional use of industrial solvents.
Production and/or modern utilization of paints, colours, lacquers, varnishes and inks.
Creation of plastics.
Production and modern utilization of pastes, organic cement, cements and tars.
Creation of canvas and textiles.
Industrial generation and formulation of wood preservatives.
Production and industrial utilization of engineered dyes, dye-intermediates and pigments.
Generation of a natural-silicone compound.
Production/formulation of medications/pharmaceutical and health care product.
Creation, and formulation of pesticides including stock-piles.
Leather tanneries.
Electronic Industry.
Pulp and Paper Industry.
Treatment of harmful chemicals and wastes.
Sterilization of utilized for the treatment of hazardous wastes/chemicals.
Air/Gases, Water and Wastewater from the process and common effluent treatment plants (CEPTS) must be refined and treated properly according to the procedure laid down by the government of India.
Organic compounds/ solvents have to go through the purification process.
Waste treatment process which is dangerous, For eg. pre-paring, incineration and concentration.
Ores containing heavy metals such as Chromium, Manganese, Nickel, Cadmium etc. must go through chemical processing.
These are a few things which are depleting our environment and which is causing a lot of imbalance for all living creatures. Various things have been mentioned under the Schedule of the Hazardous and Other Waste Management and Trans-boundary Movement) Rules, 2016.
Responsibility for Proper Management of Harmful and Other Wastes
According to Section 4 of the Hazardous and Other Wastes (Management and Transboundary Movement) Rules, 2016, these are the process that needs to be followed by various people for proper management of Hazardous Waste:
Occupier:
They should pursue anticipation, minimization, reuse, recycle, recuperation, utilisation including co-handling; safe disposal
They ought to have a safe and environmentally sound management of harmful waste.
An authorized user will receive the harmful waste created in an establishment or it will be discarded according to the authorised disposal facility.
In accordance with the guidelines laid down, the occupier’s establishment will transport the waste produced to an authorised actual user or to an authorised facility.
Storage and removal facility will be provided to the operator of that facility with such explicit data as may be required for safe storing and disposal as may be required by those who expect to get harmful waste treated and disposed of by the administrator.
They will take all the steps while managing hazardous waste to-
Provide people working on-site with appropriate training, equipment and the information necessary to ensure their safety.
Contain contaminants and anticipate accidents and confine their consequences on human beings and the environment. 
State Government:
Approval of State Government to ensure earmarking and allocation of industrial space or recycling shed, pre-processing and utilization of harmful waste in the current and upcoming industrial park has been done for the Department of industries in the State or any other government agency.
Labour department in the State or any other government agency approves in such regard by the State Government shall-
Assist the advancement of groups of workers to facilitate setting up such facilities;
Ensure, acknowledge and enlistment of workers involved in recycling, pre-processing and other utilisation activities;
To ensure the well being and health of workers involved in reusing, pre-processing and other utilisation annual monitoring must be taken;
Development exercises for the labourers engaged in recycling, pre-processing and other utilisation for the development of industrial skills;
Integrated plans for effective implementation of the provisions and submit an annual report to the Ministry of Environment, Forest and Climate Change, in the Central Government is required to be done by the State Government. 
              Click Above
Procedure for Treatment, Storage and Disposal
According to Section 16 of the Hazardous and Other Wastes (Management and Transboundary Movement) Rules, 2016 the proper procedure for treatment, storing and removal facility of hazardous and other waste is as follows:
The State government, occupier, operator of a facility or any association of occupiers will uninhibitedly or mutually or severally be held answerable for the identification of destination for establishing the workplace for treatment, storing and removal of the harmful and other waste.
According to the technical procedure issued by the Central Pollution Control Board, the operator of ordinary office or occupier of the captive facility, will plan and set up treatment, storing, and removal facility which will get an endorsement from the State Pollution Control Board for structure and configuration in this regard.
Monitoring and setting up the task of common of the task of the common, or captive treatment, storing and removal facility as per the guidelines laid down by the State Pollution Control Board.
Monitoring and setting up and the task of the common or captive treatment, storing and removal facility shall be done by the State Pollution Control Board.
According to guidelines or standard operating procedures issued by the Central Pollution Control Board, the operator of regular facility or occupier of a captive procedure will be in charge for the safety and ecological sound operation of the facility and its closure and post-closure phase.
Records of harmful and other waste dealt by the operator of common facility or occupier of a captive facility are required to be maintained under Form 3.
An Annual return under Form 4 is required to be filed by the operator of common facility or occupier of a captive facility on or before the 30th day of June following the financial year to which the returns relate to them in the format given to them by the State Pollution Control Board.
Bhopal Gas Tragedy Case
Facts
In the year 1984, India witnessed one of its most terrifying and devastating industrial disasters. In 1970 an American Enterprise, Union Carbide Corporation (UCC) established a pesticide plant in a densely populated region of Bhopal due to its central location and transportation network. The site was supposed to be used for light industrial and commercial activity. During 1984 the company was manufacturing Selvin at one-quarter of its capacity due to decreased capacity. UCIL had made arrangements to transport it to a different country due to its low decreased production. Due to low profits the company was ignoring safety standards, which the government was aware of, which further lead them to be reluctant to impose strict control.
On 3rd December 1984, massive amounts of Methyl isocyanides had engulfed the city which resulted in a loss of life for both humans and animals on a massive level. This resulted in huge loss of life and the hospital were packed with both dead bodies and clueless patients and Doctors who were not at all aware of the cause of death nor were they aware of any treatment which was not shared by the UCC group which had claimed trade secrecy as an excuse.
After the incident, UCC distance itself from its Indian subsidiary and tried to invade itself from the liability by transferring the blame on them.
The gas leak affected the lives of many, it led to various ocular, respiratory, gastrointestinal, reproductive and neurological disorders among the people. The most affected were the pregnant women who had to abort their babies, or had premature delivery or to infants with foetal abnormalities.
The grievance was also inflicted on the environment. Even after the death of so many people, the company refused to take active responsibility and restore health environment. During its production year, the company dumped a huge amount of contaminated waste outside and inside the plant site. Almost all the contamination still remain in the plant site. These waste have degraded slowly and have polluted the soil and groundwater. This threatened a lot of people and will keep on spreading until it is properly disposed of.
Judgement
In the Year 1986, the Union of India filed a complaint in the Hon’ble District Court of Bhopal in September seeking an interim compensation of Rs. 3.5 Billion, however, the Madhya Pradesh High Court diminished it to Rs. 2.5 Billion. UCC again appealed to the Hon’ble Supreme Court. The court ordered UCC to 470 Million Dollars (approx. 750 Crore Rupees) ‘in full settlement of all claims, rights and liabilities related to and arising out of the Bhopal gas calamity. In terms, all civil proceedings were concluded and criminal procedures were suppressed.
In the year 2010, Seven former representatives, including the former UCIL director, were convicted in Bhopal of causing death by negligence and sentenced to two years imprisonment and fine of 2000$.
Views
The basic negligence on the part of the company, that they had not provided proper training or had provided any safety equipment to the workers. They were not keeping a regular tab on the work or on the machinery which was being used. Due to the low sales of the company was trying to neglect things which were a safety concern for everyone. During the internal inquiry, it was found out that most of the safety systems were not working properly. This proved that UCC was only interested in the declining profits which led them to neglect the wellbeing of workers and the people near the plant, who were all killed mercilessly in an accident and negligence on the part of the Company.
It was due to this accident that the government of India felt the need to provide environment laws to protect the wildlife from this evil humanity, it was also during this time that the government also provided us with Hazardous and other waste rules, 1987.
Even after many years of the disaster, the waste is still lying around the site which polluting the soil and groundwater, which is causing a problem to the environment and the people living there. Earlier the government was not able to decontaminate the place properly as they did not have the proper procedure or methods to do so, and the company was hiding behind legal framework wherein they refused to share the information of the plant as part of their trade confidentiality.
Amendments
Over the years there have been many developments in the industry which may have led to an increase in the different types of products being introduced and being used in the development of a new product due to which there might be an increase in new types of Hazardous and Other Waste. Here are some of the major Amendments which have been made to protect the Environment. These Amendment of 2016 are as follows:
The ambit of the Rules has been extended by including ‘Other Waste’.
Waste Management grading in the procedure of priority of prevention, minimization, reuse, recycling, recovery, co-processing; and safe disposal has been incorporated.
All the procedures under the rules for permission, import/export, filing of annual returns, transportation, etc. have been re-examined altogether, demonstrating the stringent methodology for the management of such harmful and other wastes with a simultaneous simplification of procedure.
The fundamental responsibility of framework to shield the wellbeing and environment from waste handling industry has been recommended as Standard Operating Procedure (SOPs), explicit to waste type, which must be complied by the stakeholders and guaranteed by SPCB/PCC while conceding such authorisation.
The system has been simplified to unite all the approvals as freedom for setting up of harmful waste disposal facility and import of different wastes.
Streamlining and authorization procedure for co-handling of harmful waste to recoup energy and put on discharge standard premise rather than on a trial basis.
Co-preparing a particular mechanism over disposal for utilization of waste as a significant asset, or for recovery of energy has been given.
Streamlining by rearranging the record-based procedure by rethinking the list of waste regulated for the procedure for import and export of waste under the rules.
Exemption from the need of obtaining Ministry’s authorization for the import of metal scrap, paper waste and different categories of electrical and electronic hardware for reuse.
Endorsement of Standard Operating Procedure(SOPs) specific to waste type for the essential need for infrastructure to safeguard the wellbeing and environment from the waste-production industry.
Introduction to the duties of the State Government for environmentally stable supervision of harmful and other waste is as follows:
Setting up/Designating specified space or shed for the purpose of reusing, pre-processing and other utilization of harmful waste.
To ensure the safety and health of workers and attempt industrial skill development.
To enlist the workers associated in recycling, pre-processing and other utilization exercises.
To form a gathering of workers to empower setting up such facilities.
Assessment of list of techniques generating harmful waste considering inventive headway into the venture.
Reconsidering the list of waste and concentration limits according to international standard and drinking water standard.
The accompanying items have been blocked for import:
Waste edible fats and oils of animals, or vegetable cause;
Household waste;
Basic Care Medical equipment;
Tyres for direct reuse reason;
Solid Plastic wastes including Pet bottles;
Waste electrical and electronic gathering scrap;
Other chemical wastes especially in solvent structure.
Sanction by the State government to submit a yearly report to the Ministry of Environment, Forest and Climate Change and also to set up an integrated arrangement for viable execution of these provisions.
Submission by the 30th September of every year which contains a yearly inventory of waste generated, waste reused, recouped, utilised including co-processed should be done by the State Pollution Control Board.
 Amendments in the year 2019 
Solid plastic waste has been rejected from import into the country including in Special Economic Zones (SEZ) and by Export Oriented Units (EOU).
Exporters of silk waste have now been given prohibition from requiring authorisation from the Ministry of Environment, Forest and Climate Change.
Electrical and electronic assemblies and segments manufactured in and exported from India if found damaged can now be imported back into the nation, within a year of export, without obtaining consent from the Ministry of Environment, Forest and Climate Change.
Ventures which do not require consent under Water (Prevention and Control of Pollution) Act 1974 and Air (Prevention and Control of Pollution) Act 1981, are now exempted from requiring approval under the Hazardous and Other Wastes (Management & Trans-boundary Movement) Rules, 2016, provided that hazardous and other wastes generated by such enterprises are handed over to the lawful actual users, waste collectors or disposal facilities.
Other Legislation for Environment Protection
Ministry of Economic Environment was established in the year 1985, it is the apex body which provided rules and regulations for protecting the environment. It has laid down many statutory rules to protect the environment those are:
The National Green Tribunal Act, 2010
The Air (Prevention and Control of Pollution) Act, 1981
The Water (Prevention and Control of Pollution) Act, 1974
The Environment Protection Act, 1986
Hazardous Waste Management Regulations
E-Waste (Management and Handling) Rules, 2011
Batteries (Management & Handling) Rules, 2001
The Wildlife Protection Act, 1972
The Forest Conservation Act, 1980
Public Liability Insurance Act, 1991
The Biological Diversity Act, 2002
Coastal Regulation Zone Notification
Conclusion 
It is not easy for people to cope with the Bhopal Gas Tragedy, they still feel for their loved ones. They are still not able to live a proper healthy life, still children are being born with diseases and complaint it is hard for them to live. Every industry should follow these safety protocols to dispose of these hazardous waste, they should make sure that no other person is affected by these harmful waste.
  The post Handling of Hazardous Substances and Legal Provisions appeared first on iPleaders.
Handling of Hazardous Substances and Legal Provisions published first on https://namechangers.tumblr.com/
0 notes
myabhijitr · 5 years ago
Text
Levodopa Market - Size, Share, Outlook, and Analysis by 2018-2026
Development of novel formulations and efficient drug delivery methods for levodopa are expected to drive growth of the levodopa market. For instance, a clinical study for gastric retentive Accordion Pill, an immediate drug release formulation by Intec Pharma Ltd., is ongoing in clinical phase III and is expected to complete in September 2018. Accordion Pill is a Carbidopa/Levodopa (AP-CD/LD) combinational oral drug delivery system, which is designed to improve the efficacy and safety of existing CD/LD drugs by utilizing an efficient gastric retention and specific release mechanism.
Moreover, Impel NeuroPharma Inc. is conducting phase II clinical study for INP103, a drug-device combination product containing a drug component, L-dopa, and device component I231 Precision Olfactory Delivery (POD) device. The study is expected to complete in November 2018.
Get Request sample copy for Industry Insight: https://www.coherentmarketinsights.com/insight/request-sample/2247
Furthermore, advancement in diagnosis of Parkinson's disease (PD) progression is expected to boost growth of levodopa market. For instance, a clinical study conducted by Washington University School of Medicine, for measuring PD progression both by using Magnetic Resonance Imaging (MRI) and by controlled dose of levodopa for discovering suitable biomarker of PD is currently in clinical phase I and is expected to complete in February 2019.
Shortage of drug supply in the market due to delay in manufacturing and supply of levodopa is expected to hamper levodopa market growth. For instance, Merck Sharp & Dohme Ireland (Human Health) Ltd. in September 2018, anticipated stock shortage of some Sinemet (Carbidopa/ Levodopa) products in the Irish market in near future due to global manufacturing delays in production and demand for resupply of these products.
North America is expected to dominate the global levodopa market, owing to approval of new products by the U.S. Food and Drug Administration (FDA). For instance, in 2015, FDA approved an extended-release oral formulation of Levodopa/Carbidopa called Duopa, manufactured by AbbVie Inc., in the U.S. market. Duopa is a gel formulation of Carbidopa/Levodopa enteral suspension and is administered using a small, portable infusion pump that delivers Carbidopa and Levodopa directly into the small intestine, which continuously release over 16 hours in the body.
Purchase Copy of This Business Research Report: https://www.coherentmarketinsights.com/insight/buy-now/2247
Europe region is expected to witness significant growth in levodopa market due to involvement of key players for marketing novel formulations in European region. For instance, Acorda Therapeutics, Inc., in March 2018, submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for INBRIJA, an investigational inhaled levodopa treatment for symptoms of OFF periods (OFF symptoms implies recurrence of symptoms such as rigidity, and tremors after long period of levodopa use) in people with PD taking a Carbidopa/Levodopa regimen.
The key players operating in levodopa market include, Taj Pharmaceuticals Limited., Guangzhou HanFang Pharmaceutical Company Limited, Poulvet.com, Teva Pharmaceutical Industries Ltd., UBM, Zhejiang Wild Wind Pharmaceutical Co., Ltd., and SWAPNROOP.
0 notes
Text
Levodopa Market Positive Long-Term Growth Outlook 2018-2026
Tumblr media
Levodopa or L-Dopa is a chemical building-block that converts into a dopamine in body. Dopamine is the chemical messenger released in brain. It mediates pleasure, cognition, and memory functions. Nearly all patients receive the dopamine precursor levodopa, which adequately control symptoms of Parkinson's disease (PD) at early stage of the disease. Carbidopa is often included with levodopa-containing drugs in order to boost its efficacy by slowing down the metabolism of dopamine. Click To Read More On Levodopa Market
Levodopa Market Driver
Development of novel formulations and efficient drug delivery methods for levodopa are expected to drive growth of the levodopa market. For instance, a clinical study for gastric retentive Accordion Pill, an immediate drug release formulation by Intec Pharma Ltd., is ongoing in clinical phase III and is expected to complete in September 2018. Accordion Pill is a Carbidopa/Levodopa (AP-CD/LD) combinational oral drug delivery system, which is designed to improve the efficacy and safety of existing CD/LD drugs by utilizing an efficient gastric retention and specific release mechanism.
Moreover, Impel NeuroPharma Inc. is conducting phase II clinical study for INP103, a drug-device combination product containing a drug component, L-dopa, and device component I231 Precision Olfactory Delivery (POD) device. The study is expected to complete in November 2018.
Furthermore, advancement in diagnosis of Parkinson's disease (PD) progression is expected to boost growth of levodopa market. For instance, a clinical study conducted by Washington University School of Medicine, for measuring PD progression both by using Magnetic Resonance Imaging (MRI) and by controlled dose of levodopa for discovering suitable biomarker of PD is currently in clinical phase I and is expected to complete in February 2019.
Levodopa Market Restraint
Shortage of drug supply in the market due to delay in manufacturing and supply of levodopa is expected to hamper levodopa market growth. For instance, Merck Sharp & Dohme Ireland (Human Health) Ltd. in September 2018, anticipated stock shortage of some Sinemet (Carbidopa/ Levodopa) products in the Irish market in near future due to global manufacturing delays in production and demand for resupply of these products.
Competitive Landscape
The key players operating in levodopa market include, Taj Pharmaceuticals Limited., Guangzhou HanFang Pharmaceutical Company Limited, Poulvet.com, Teva Pharmaceutical Industries Ltd., UBM, Zhejiang Wild Wind Pharmaceutical Co., Ltd., and SWAPNROOP.
Levodopa Market – Regional Analysis
On the basis of region, the global levodopa market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
North America is expected to dominate the global levodopa market, owing to approval of new products by the U.S. Food and Drug Administration (FDA). For instance, in 2015, FDA approved an extended-release oral formulation of Levodopa/Carbidopa called Duopa, manufactured by AbbVie Inc., in the U.S. market. Duopa is a gel formulation of Carbidopa/Levodopa enteral suspension and is administered using a small, portable infusion pump that delivers Carbidopa and Levodopa directly into the small intestine, which continuously release over 16 hours in the body.
Ask For Sample Copy Of This Business Research Report : https://www.coherentmarketinsights.com/insight/request-sample/2247
Europe region is expected to witness significant growth in levodopa market due to involvement of key players for marketing novel formulations in European region. For instance, Acorda Therapeutics, Inc., in March 2018, submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for INBRIJA, an investigational inhaled levodopa treatment for symptoms of OFF periods (OFF symptoms implies recurrence of symptoms such as rigidity, and tremors after long period of levodopa use) in people with PD taking a Carbidopa/Levodopa regimen.
Furthermore, in November 2015, Impax Laboratories, Inc. received European Commission (EC) marketing authorization for NUMIENT (Levodopa and Carbidopa), a modified-release oral capsule formulation for the symptomatic treatment of adult patients with Parkinson's disease in Europe region.
Also, Coherent Market Insights has a proprietary database of pipeline biologics and biosimilars, called PHASE-XS. This database provides analytical data in addition to the clinical information of ongoing trials for biologics and biosimilars. An amalgamation of more than 30 parameters, PHASE-XS helps biotechnology and pharmaceutical companies to analyze the market trend, competition, and market potential. For more information or to access this database, kindly click on the below link or contact at [email protected]
https://www.coherentmarketinsights.com/phase-xs/
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: [email protected]
0 notes
demondeanismybaby · 8 years ago
Text
Stood Up Again, ... wait.
Pairing: AgentSmith!Sam x reader, mentions of OMC
Word count: 2533
Warnings: Fluff, one night stand, semi public sex, unprotected sex, generally smuttiness
Summary: After getting stood up by your boyfriend, and questioned by the FBI you are thinking your life is getting a little off track, but maybe things could all work out in the end.
A/N: I thought about this one shot, there is not enough of Sam having one night stands, he should do that more according to me. For Smut Appreciation Day.
Tumblr media
You fiddled with the pages of the wine list, glancing down at various French vineyards, before looking over at the frosted glass entrance. Bryan was supposed to meet you there at 8, you thought it was strange he picked out such a nice restaurant, but you were telling yourself not to overthink it. Valentines day was next weekend, maybe he was just trying to step up his game.
You tapped on the screen of your phone, 8:47pm, and there were no missed calls or texts. After you had called him, and gotten his voicemail, and sent a text twenty minutes ago you could feel the strange emptiness in your stomach, something awful was going on.
“Excuse me, Y/F/N, Y/L/N?”
You felt the slight touch on your shoulder, hope swelling, only to immediately crash at the strangers voice. You moved a little in your chair, so you were able to face him, “Yes?”
He flashed an official looking FBI badge at you, increasing your dread about Bryan, “I need to ask you a couple of questions.” He didn’t wait on you to say yes or no, just sat across from you, and you felt his knees bump against yours at the intimate table.
Starting his spiel, you quickly became disinterested it had nothing to do with your fiance, then you heard the soft ding and snatched up your phone. Your blood boiled as you read it, he wasn’t coming, so sorry, late night at work, the same excuses except this time you were left eating fancy salad and drinking imported wine instead of a beer and wings.
“Miss?” A giant hand crossed over the words on your phone, and you were snapped out  of your jilted musings to be reminded it wasn’t the only thing on your plate.
Trying to force an apologetic smile, wondering if you looked a little like you were drunk as the edge of your mouth twitched, “sorry, long day, I didn’t catch what you were saying.”
He was a little apprehensive, you could see a slight frown and a worried shimmer in his eyes, “I was saying my name is Agent Smith, we are currently looking into a case involving Meyer Pharmaceuticals, and I was wondering if you could tell me anything about their day to day operation.”
Briefly focusing on his question, “why would you want to talk to me about it? I am an intern the only thing I do there is make copies and get coffee.” You weren’t angry he wanted to talk to you, but you really didn’t see why he wanted to get the interns opinion, you were underpaid, overworked, and no one there even called you by your name. You doubted that you could crack open an FBI investigation on the place.
“What I am looking for is information about a,” he pulled out a small black notebook, “Carla Tillman.”
“Carla? She is the office manager,” you racked you head for anything he would find substantial but you were blank, only petty things came to mind like her weird obsession with tiny ceramic unicorns, or the way her perfume was always so heavy it made you gag when you went to grab whatever copies she needed made, “what is it that you want to know about her?”
He kept asking you questions, stuff that didn’t seem all that important, and you kept checking your phone as you gave brief answers growing angry again at being left here while your boyfriend hadn’t even asked if you had made it home. Then Agent Smith asked you something that distracted you completely.
“So if you don’t mind me asking, is this normally the type of place you come by yourself?”
“No, actually I got stood up,” and even though you tried to keep out the bitterness you couldn’t help but add, “again.”
He blushed a little at your answer, “I’m sorry to hear that,” then he smiled, it was dazzling the way it changed his whole personality and you noticed how handsome he was, “he must be an idiot.”
You thought it was weird how quickly the conversation changed after that, you started just chatting asking you about you about your job, what kind of places you did normally hang out at, you noticed he didn’t really open up himself but occasionally he would let something slip about his brother or how much he loved to read. As he called over the waiter, it had been almost two hours, and you felt a little disappointment. You were silently delighted when he dropped his own card down on the bill he winked, “it’s on Uncle Sam.”
Grasping your purse as you stood up to leave, you hesitated for second, then you forced yourself to do something crazy. Pulling out a company card, with your own cell number scribbled at the bottom, you slid it into his hand as he offered one last shake before leaving.
“If you stay in town for a while, maybe you could give me a call.” You knew you should feel guilty even mildly flirting with another guy, but you doubted anything would come from it, his mouth opened in silent surprise but he quickly changed it into a smile and nodded.
It had been two days of looking at your phone every chance you got, because a lot had changed. You had left the dinner with Agent Smith, you never did find out his first name, and you had called Bryan. There was obviously no answer so when you heard his bland voicemail you had told him you were done, no more waiting on him or being stood up, he had tried to get you to change your mind but it was over.
Something about the ease that you were able to imagine being with someone else that night, even a stranger, was enough to make you aware that you needed more. Even though you doubted the FBI let their agents go out with people they questioned after the way you had gotten along so well you were still hopeful.
“Y/n, can you put down the phone.”
Shoving it quickly out of sight, you focused on what you were supposed to be doing, “Yeah sorry, family things.” Carla didn’t look fooled. Then the look morphed into a glare as your phone started ringing.
“I’m going to go get the rest of those papers off your desk,” you dashed out of the copy room and as you got around the corner of the row of cubicles, you answered without even a cursory glance at the number.
“Hello?”
“Miss Y/L/N?”
Your cheeks hurt as the muscles strained because of the huge smile at the voice on the other line, he had decided to call you after all, even though as you continued to talk you were getting a little less excited since it was obviously a work thing. He wanted to come over to see the offices and would you be able to show him around. You let him know you only had access to the office section of the building, it was mostly cubicles where people called different hospitals to try and get them to stock the pharmaceutical companies medications, but that you would be happy to.
Standing out near the employee entrance to the side of the building, you shifted your weight, you had been running a little late to meet him and now you didn’t see anyone else around. Maybe he had decided he couldn’t wait on you. When you saw his tall frame coming around the building though you relaxed and waved to catch his eye.
He hurried his pace and beamed at you as he pushed his hair back out of his face. “Y/n thanks for doing this.”
“No problem, hey can I ask what your first name is?”
He hesitated, you thought maybe you were crossing a line, then he stammered out, “it’s Sam.”
You pulled a face.
“What?”
“Your name is Sam? Sam Smith? Like the singer.”
He laughed, it shook his whole body, and he balanced himself on his knees with the force of it. You weren’t really sure why it was so funny but his energy was so inviting you found yourself wanting to join in. Eventually he calmed down, “Sorry my name is actually Samuel but I go by Sam, I guess I never made the connection.”
“Well lets show you around Sam.” You swiped your ID badge over the small black panel and then when the tiny light went from red to green, you swiftly pushed open the door.
Sam’s company made up for the boring tour you were giving, he was making little jokes about the various things that were bland to you seeing them every day, he made you giggle and snort as you tried to keep quiet so you didn’t draw too much attention to the two of you.
It wasn’t exactly the Taj Mahal so in about fifteen minutes you had wandered through the areas you were allowed access to, and you pulled open the last door. Inside was a small table that had a jar of pens, papers, a hole punch on it. Opposite the copier, it was only slightly better lit that the average closet or coffin but you liked it anyway. It was where you went to escape your annoying co-workers.
“I doubt the ax murderer has any secret plans for these safety scissors,” you said picking up a pair to snap at him menacingly, “I just like it in here.”
He was looking out into the hallway, not really acknowledging you, which kind of stung. Then he stepped forward shutting the door, you stomach clenched at the scent of his cologne it wasn’t pungent but his closeness had it wrapping around you, but as he leaned closer you thought maybe he was going to tell you something secret about the case and figured you should focus.
“About the other night,” you felt the warmth against your ear as he spoke, “you should know I won’t be in town long we’ve almost finished the case.”
You turned to look at him, but you misjudged his closeness and you felt the hard knock and water crept into your eyes as your nose smacked into the back of his head, “God sorry,” you said as you watched him start rubbing the spot you had hit. 
“No problem,” he hair covered his face, so you had no way to gauge his expression, his shoes were suddenly very interesting apparently.
A second later the sting had gone away so you reached for him, “well that’s too bad, about leaving soon I mean.”
His gaze snapped up at that, pausing on where your hand rested against him, then locked onto your eyes. Deciding to be a little bolder, you typically were a long term relationship kind of girl, you added, “I was wanting to see about giving the whole rebound thing a try since I am officially single.”
He started to press in closer to you, pausing briefly, but when you didn’t back away he was on you. Turning you, you felt a sting as your tailbone hit the hard edge of the table, it was cramped. He was clearly aware of your location though because instead of trying to undress you he just lifted your skirt and pulled your panties halfway off, to steady yourself you pushed against his chest, but he planted his hands on your waist and set you on the edge of the table. You felt papers sliding onto the ground and underneath you, and you held off the urge to start laughing.
The sound of his zipper, had you panting in an instant, being at work where anyone could walk in and see you was intoxicating. He was standing a little away from you and you were drawn to where he was working himself.
“Touch yourself,” his voice was strained.
You knew without glancing up he was watching you, so you wet your fingers before sliding them against yourself. He let out a small groan as you lifted you skirt a little more and tried with your panties twisted up around you to spread your knees.
As soon as you started to work you noticed the echos, his hand on skin and as you got going your own slickness, then he came closer.He tugged at your wrist and then capturing it brought your fingers to his lips, his tongue swirled along them, when he released you he felt him pressing into you.
Shifting down a little you tried to make it easier for him. That’s when you felt him enter you, the pace he set was quick and the table under you kept knocking against the wall, you didn’t even care if anyone heard though because you could felt him run a finger over you clit and electricity shot through you.
“God,” you couldn’t even remember his name, “ Agent, feels so good.” Barely able to make the words leave your mouth past your clenched teeth.
He rested his head on you, nipping at your clavicle. You felt his head damping the sweater you were still wearing. You tangled your hand in his hair and the other wrapped around his upper arm for purchase and you began to rock your hips.
Picking up the pace you knew he was close, he was pulling up and his eyes locked on yours, putting your hand between your bodies you were able to frig your self. You were right on the edge and then you were tightening around him, heat was rolling through you.
Suddenly he pulled out and you knew he was ready so you scuffled off the table and onto your knees his free hand steadying you while you got down.
“Stick your tongue out,” he was panting it but you got the idea.
You opened your mouth wide and closed your eyes and waited and then he was pushing the tip of himself against your lips and you were flooded with the deep tang which you swallowed down.
He was still breathing heavy, and you knew as you stood up and tried to straighten yourself that if anyone saw either of you, it was going to be more than obvious what you just finished. His suit was wrinkled and dark with sweat and you could feel the weird way your hair was standing as your tried to smooth it with your palm.
“So, Smith,” his last name was still all you could think of, “you should probably get back to work.” You giggled there were no hard feelings it had been a good time for both of you.
He beamed at you, his teeth were showing, “I finished the case the other night.”
“Really?” You face must have shown your shock because he started to laugh.
“Yeah I just wanted to see you again,” he said after calming, “I wasn’t expecting this though, my partner is going to give me a hell of a time.”
“Well, you always have my number if you are ever back in town.” You had no expectations, you didn’t even really mind that this was a one time thing, you were looking forward to having more fun experiences now that you were single.
Turning towards the door you were stopped by his giant arms wrapping around you, it was sweet and you got the feeling if he didn’t have this type of job he wouldn’t be the kind of guy to watch a chick walk out after a quicky, “I really hope I get a chance to use it.”
24 notes · View notes
vsplusonline · 5 years ago
Text
India braces for more coronavirus cases, but experts fear an epidemic
New Post has been published on https://apzweb.com/india-braces-for-more-coronavirus-cases-but-experts-fear-an-epidemic/
India braces for more coronavirus cases, but experts fear an epidemic
India is bracing for a potential explosion of coronavirus cases as authorities rush to trace, test and quarantine contacts of 31 people confirmed to have the disease.
It is screening international travelers at 30 airports and has already tested more than 3,500 samples. The Indian army is preparing at least five large-scale quarantine centers.
For weeks, India watched as cases of COVID-19, the disease caused by the virus, multiplied in neighboring China and other countries as its own caseload remained static — three students evacuated from Wuhan, the disease epicenter, who were quarantined and returned to health in the southern state of Kerala.
READ MORE: Coronavirus cases top 100,000 worldwide, sparking global economy concerns
Prime Minister Narendra Modi’s government said last week that community transmission is now taking place. India has shut schools, stopped exporting key pharmaceutical ingredients and urged state governments to cancel public festivities for Holi, the Hindu springtime holiday in which people douse each other with colored water and paint.
Story continues below advertisement
Modi canceled travel plans to Brussels for an India-EU summit amid a rising caseload in Belgium, and tweeted that he would not attend any Holi festivities.
3:44 COVID-19: PAHO prioritizes Haiti, Venezuela, migrant populations for coronavirus support
COVID-19: PAHO prioritizes Haiti, Venezuela, migrant populations for coronavirus support
Experts fear these precautions won’t be enough for India’s beleaguered, under-funded and under-staffed health system to stave off an epidemic. Here are their foremost concerns:
Too few labs, not enough hospitals
As the virus spread globally, India began bolstering its ability to test and detect the virus. While the National Institute of Virology at Pune remains the main testing facility, the government has identified 35 additional labs for testing.
But concerns remain over India’s overstretched health infrastructure — a single state-run hospital for every 55,591 people on average and a single hospital bed for every 1,844 people. India needs about 10 times more doctors to meet the norms prescribed by the World Health Organization, a shortfall of at least 500,000 doctors.
READ MORE: China sees cautious return to work after weeks of disruption due to COVID-19
Experts fear that an epidemic would cause other routine health care functions to suffer.
“Everything will become about COVID-19. And other routine services like immunization or taking care of maternal mortality would be affected,” said Anant Bhan, a global health and policy expert.
Story continues below advertisement
Health care inequality
India’s health performance, an index that includes access to primary care, maternal mortality rates and child health, runs the spectrum, with some states outperforming others by almost 2.5 times, according to the government-run think tank NITI Aayog.
The best performer was Kerala, the small state that found and treated India’s first three cases. The worst was Uttar Pradesh, a state with roughly the population of Brazil that has detected at least six cases. Kerala has a doctor for approximately every 6,000 people, while Uttar Pradesh has one for every 18,000 people. The inequalities are further pronounced between urban and rural areas, with the bulk of the available beds concentrated in India’s cities.
India spent an average of $62.72 per person on health care in 2016, according to WHO, compared to China’s $398.33.
READ MORE: U.S. stocks open sharply lower, bond yields sink over brewing coronavirus worries
Inequalities could make prevention even harder. In places with limited access to clean water, washing hands to prevent the spread of the virus is difficult, said Dr. Gagandeep Kang, a microbiologist who heads India’s Translational Health Science and Technology Institute.
Retired virologist and pediatrician Dr T. Jacob John said these inequalities aren’t just a reflection of not spending enough on health care, but also of not knowing where to spend.
“The last time a needs-based survey was done for India’s health care was in 1946,” he said, adding that the country’s “health management system is very inadequate for India’s existing problems, let alone new ones.”
Story continues below advertisement
Quarantine millions
India’s health minister told Parliament that the “need of the hour” is to contain viral clusters, to prevent and break chains of transmission. But in India, with a population of 1.4 billion, that is far from easy.
Take the city of Agra, famous for the Taj Mahal, where six Italian tourists tested positive for the virus. Apart from the 40,000 tourists who visit the monument each day, the city has a population of more than 4 million, with nearly 3,000 people crammed into every square mile. Following WHO advice, the Indian government has told people keep a distance of at least six feet from others.
But “anywhere you’ve a dense population, all the issues of social distancing become challenging,” Kang said.
1:56 Coronavirus outbreak: WHO praises role of women in fighting COVID-19
Coronavirus outbreak: WHO praises role of women in fighting COVID-19
Short on medicines
With the virus lockdown in China resulting in shortages in India, the government halted the export of 13 key drug ingredients and the medicines made from them on Tuesday.
Although India is the world’s primary supplier of generic drugs, it relies on China for nearly 70% of the active pharmaceutical ingredients it uses for making medicines.
READ MORE: Do you think you have coronavirus symptoms? Here’s who to call first
India has said it has enough stocks, but the government’s minister for chemicals and fertilizers told Parliament that there remains “an apprehension” that supplies of ingredients from China would be disrupted if the epidemic continues.
Story continues below advertisement
Long-term response
On Thursday, Health Minister Harsh Vardhan met the management of India’s top private hospitals to ask them to work with the government in dealing with the outbreak, and urged them to “prepare a pool of beds.”
Kang said India’s current approach, which is focused on travelers, might restrict some cases. But eventually, it will have to expand testing to limit the spread of the disease within the country, Kang said. The question, she said, is whether authorities want to do that now, or at the height of an epidemic.
© 2020 The Canadian Press
JOURNALISTIC STANDARDS
REPORT AN ERROR
Source link
0 notes
titheguerrero · 7 years ago
Text
A Higher Impunity - How Can we Reduce Health Care Leadership's Impunity When the President Claims His Own Impunity?
Impunity: an Introduction We believe that unaccountable leadership is a major cause of health care dysfunction.  Impunity is an extreme form of unaccountable leadership. We have noted that despite numerous legal settlements made by health care organizations of alllegations like fraud, bribery, and kickbacks, almost never do top leaders who presided over these actions face any negative consequences.  Lack of deterrence caused by such impunity appears to be a major cause of  the epidemic of continuing unethical behavior, crime and corruption on the part of large health care organizations. How executives got to the point of having such impunity has never been clear. Timidity and lenience by regulatory agencies and law enforcement seem to be factors. For example, in 2014, we noted  that Attorney  General Eric Holder had previously been reluctant to go after big organizations because of the economic consequences of their failure:
The attorney general angered many last year when he reiterated those concerns at a congressional hearing, admitting 'that the size of some of these institutions becomes so large that it does become difficult for us to prosecute' because of the potential nasty economic effects of a major company failure.
In general we have seen much tougher enforcement directed against relatively small health care players than against bigger ones.  For example, we noted in 2014 that settlements by  Merck, Eli Lilly, Takeda, and Teva, all large pharmaceutical companies, allowed the companies to pay fines to settle allegations that they pushed dangerous products, while none of the executives who authorized, enabled, or directed these actions faced negative consequences.  In contrast, at that time, the CEO of a relatively tiny Sheffield Pharmaceuticals was convicted of a felonious wastewater discharge (see this post). However, this rationale does not address the failure to pursue enforcement actions against organizational leaders who who enabled, authorized, directed or implemented misbehavior.  It is not that there are no good legal tools available to do so.  We wrote in 2012,
As we noted here, a Supreme Court case from 1943 empowered the government to seek penalties against responsible corporate officers (the "responsible corporate officer doctrine") who were in a position to stop a fraud that resulted in a guilty plea or conviction, particularly for the selling of misbranded or adulterated drugs into interstate commerce under the US Food and Drug Act.    Despite a threat made in 2010 by the chief counsel of the Inspector General's office of the US Department of Health and Human Services to use such legal authority to "get high level executives out of companies," nothing of the sort has happened.
Later, in 2015, under the previous administration, there was a tiny sign of progress against impunity.  Then, Attorney General Holder authorized the creation of a Corporate Strike Force to take strong actions in response to health care corporate fraud.  However, last year the Trump administration gutted even that small effort  (look here). Why are efforts to reduce the impunity of health care corporate leaders going backward?  It may be because the very top leadership of the current administration, that is, the President himself, has long personally enjoyed his own impunity. Examples of Donald Trump and Family's Apparent Impunity Before He Became President As a wealthy businessman, Donald Trump and his family were often linked to apparently illegal activities, but seemed to avoid any intensive investigation, much less negative consequences. A 2016 Politico article cataloged Trump's ties to organized crime, and found "Some of Trump’s unsavory connections have been followed by investigators and substantiated in court; some haven’t." Also,
Trump’s career has benefited from a decades-long and largely successful effort to limit and deflect law enforcement investigations into his dealings with top mobsters, organized crime associates, labor fixers, corrupt union leaders, con artists and even a one-time drug trafficker whom Trump retained as the head of his personal helicopter service.
We have found numerous examples, whic are below listed chronologically according to the time of occurrence of relevant events. Trump Accused of Lying to Federal Investigators about his Mafia Connections in the 1980s A WNYC piece from October, 2016, was based on an interview with a federal prosecutor who had investigated organized crime in the 1980s,
Attorney Kenneth McCallion was one of the federal prosecutors involved in that investigation. He says there appeared to be a sweetheart deal between the Teamsters Local 282 and Trump, where Trump would get a promise of cooperation from organized labor—including breaking up any strikes by minority workers—in exchange for no-show jobs, a lucrative concrete contract and a luxury apartment for the union president's girlfriend. 'After we indicted them, the Teamster leaders called a citywide strike, but there were two job sites they exempted from that. One was Trump Tower and the other was Trump Plaza,' McCallion said. Yet despite this, Trump was never prosecuted. 'Even though Donald Trump lied to law enforcement about his relationship and lying to federal agents is a federal crime, he basically got a pass at that point,' he said.
Trump Accused in Legal Papers of Accepting Kickbacks, but the Charges were not Investigated The 2016 Politico article also noted:
[An associate of a convicted racketeer] in court papers accused Trump of taking kickbacks from contractors, asserting this could 'be the basis of a criminal proceeding requiring an attorney general’s investigation' into Trump. Trump then quickly settled, paying the woman a half-million dollars.
No further investigation ensued. After a Judge Found that he Conspired to Violate Fiduciary Duty and Committed Fraud, Trump was able to Settle with Details Sealed Again in Politico,
In 1991, a federal judge, Charles E. Stewart Jr., ruled that Trump had engaged in a conspiracy to violate a fiduciary duty, or duty of loyalty, to the workers and their union and that the 'breach involved fraud and the Trump defendants knowingly participated in his breach.' The judge did not find Trump’s testimony to be sufficiently credible and set damages at $325,000. The case was later settled by negotiation, and the agreement was sealed.
It is not clear that Trump was personally responsible for paying whatever the settlement entailed.  No criminal charges apparently followed.   Applying for a Casino License, Trump Failed to Disclose he was Under Grand Jury Investigation, but Later Kept his License As also reported by Politico, when Trump was trying to obtain a license for a New Jersey gambling casino,
Trump was required to disclose any investigations in which he might have been involved in the past, even if they never resulted in charges. Trump didn’t disclose a federal grand jury inquiry into how he obtained an option to buy the Penn Central railroad yards on the West Side of Manhattan. The failure to disclose either that inquiry or the Cody inquiry probably should have disqualified Trump from receiving a license under the standards set by the gaming authorities.
But it didn,'t. And despite the fact that
Once Trump was licensed in 1982, critical facts that should have resulted in license denial began emerging in Trump’s own books and in reports by Barrett—an embarrassment for the licensing commission and state investigators, who were supposed to have turned these stones over. Forced after the fact to look into Trump’s connections, the two federal investigations he failed to reveal and other matters, the New Jersey Division of Gaming Enforcement investigators circled the wagons to defend their work. First they dismissed as unreliable what mobsters, corrupt union bosses and Trump’s biggest customer, among others, had said to Barrett, to me and other journalists and filmmakers about their dealings with Trump. The investigators’ reports showed that they then put Trump under oath. Trump denied any misconduct or testified that he could not remember. They took him at his word. That meant his casino license was secure even though others in the gambling industry, including low-level licensees like card dealers, had been thrown out for far less.
Trump's Casino Company Paid Multiple Fines for Violating Regulations, but Trump was not Personally Sanctioned  An Atlantic article from January, 2017, stated,
Trump has been repeatedly fined for breaking rules related to his operation of casinos. In 1990, with Trump Taj Mahal in trouble, Trump’s father Fred strolled in and bought 700 chips worth a total of $3.5 million. The purchase helped the casino pay debt that was due, but because Fred Trump had no plans to gamble, the New Jersey gaming commission ruled that it was a loan that violated operating rules. Trump paid a $30,000 fine; in the end, the loan didn’t prevent a bankruptcy the following year. As noted above, New Jersey also fined Trump $200,000 for arranging to keep black employees away from mafioso Robert LiButti’s gambling table. In 1991, the Casino Control Commission fined Trump’s company another $450,000 for buying LiButti nine luxury cars. And in 2000, Trump was fined $250,000 for breaking New York state law in lobbying to prevent an Indian casino from opening in the Catskills, for fear it would compete against his Atlantic City casinos.
Also, while Trump was attempting a hostile take-over of a rival casino,
the Federal Trade Commission fined him $750,000 for failing to disclose his purchases of stock in the two companies, which exceeded minimum disclosure levels.
Trump and Family were Accused of Self-Dealing and Accepting Illegal Donations while Operating the Trump Foundation, but were not Individually Penalized Also reported by the Atlantic,
The [Trump] foundation appears to have broken IRS rules on 'self-dealing” by paying to resolve the legal disputes as well as buying a portrait of Trump and a Tim Tebow helmet that went back to the Trump family. In November, in tax filings posted online, the Trump Foundation said it had violated self-dealing rules in 2015 and in previous, indeterminate, years. On the donation, Trump and Bondi both say there was no quid-pro-quo, but the donation was an illegal one for a charitable nonprofit, and the foundation had to pay a $2,500 fine. Liberal watchdog group Citizens for Responsibility and Ethics in Washington charges other laws may have been broken as well. New York Attorney General Eric Schneiderman has reportedly launched an investigation into the foundation. Schneiderman has also informed the foundation that it is in violation of rules on fundraising and ordered it to quit. Trump has announced plans to shutter his foundation, but reportedly cannot do so while it is under investigation.
Yet so far no person has been charged with any related violations. Note that it appears that Trump may have had leverage on Mr Schneiderman, who has now resigned (see below).  Although there were reports in 2017 that the Foundation was going to shut down, as of March, 2018, according to an article in The Hill, the ranking Democratic member of the House Oversight and Government Reform Committee was still trying to get records related to the self-dealing described above from the leadership of the apparently still existing foundation (look here).  Trump's Taj Mahal Casino Was Fined for Breaking Rules about Money Laundering, but Trump Paid no Penalties A May, 2017, CNN story stated,
The Trump Taj Mahal casino broke anti-money laundering rules 106 times in its first year and a half of operation in the early 1990s, according to the IRS in a 1998 settlement agreement. It's a bit of forgotten history that's buried in federal records held by an investigative unit of the Treasury Department, records that congressional committees investigating Trump's ties to Russia have obtained access to, CNN has learned. The casino repeatedly failed to properly report gamblers who cashed out $10,000 or more in a single day, the government said. Trump's casino ended up paying the Treasury Department a $477,000 fine in 1998 without admitting any liability under the Bank Secrecy Act.
There is no record suggesting anyone looked into Trump's involvement with these violations. Note that
The 1998 settlement was publicly reported at the time, and the Associated Press noted it was the largest fine the federal government ever slapped on a casino for violating the Bank Secrecy Act.
However,
But key details of the casino's cash reporting violations are missing from the publicly released documents, including the identities of the gamblers and casino employees involved in the transactions.
Then, in 2015, FINCEN publicly announced:
The Financial Crimes Enforcement Network (FinCEN) today imposed a $10 million civil money penalty against Trump Taj Mahal Casino Resort (Trump Taj Mahal), for willful and repeated violations of the Bank Secrecy Act (BSA). In addition to the civil money penalty, the casino is required to conduct periodic external audits to examine its anti-money laundering (AML) BSA compliance program and provide those audit reports to FinCEN and the casino’s Board of Directors. Trump Taj Mahal, a casino in Atlantic City, New Jersey, admitted to several willful BSA violations, including violations of AML program requirements, reporting obligations, and recordkeeping requirements. Trump Taj Mahal has a long history of prior, repeated BSA violations cited by examiners dating back to 2003. Additionally, in 1998, FinCEN assessed a $477,700 civil money penalty against Trump Taj Mahal for currency transaction reporting violations. 'Trump Taj Mahal received many warnings about its deficiencies,' said FinCEN Director Jennifer Shasky Calvery. 'Like all casinos in this country, Trump Taj Mahal has a duty to help protect our financial system from being exploited by criminals, terrorists, and other bad actors. Far from meeting these expectations, poor compliance practices, over many years, left the casino and our financial system unacceptably exposed.' Trump Taj Mahal admitted that it failed to implement and maintain an effective AML program; failed to report suspicious transactions; failed to properly file required currency transaction reports; and failed to keep appropriate records as required by the BSA. Notably, Trump Taj Mahal had ample notice of these deficiencies as many of the violations from 2012 and 2010 were discovered in previous examinations.
Again, there is no record of any negative consequences for Mr Trump Trump Made False Statements Under Oath, but was not Charged with Perjury A Mother Jones article published February, 2016, recounted that in connection with a libel suit Mr Trump filed against journalist Timothy O'Brien alleging O'Brien under-reported Mr Trump's wealth,
In 2007—two years before a New Jersey judge tossed out the case—Trump was questioned during a deposition. Over the course of the two-day-long interrogation, Trump was forced repeatedly to acknowledge having made false statements. And at one point, a lawyer for O’Brien and his publisher asked Trump a straightforward question: Have you ever before associated with individuals you knew were associated with organized crime?' Trump, who was testifying under oath, answered, 'Not that I know of.' That was a clear and unequivocal response. But it was not true. Two years earlier, O’Brien had interviewed Trump and specifically asked him about Sullivan and Shapiro. O’Brien, now an editor and writer at Bloomberg, has provided Mother Jones with a transcript of the interview, and it conclusively shows that Trump believed that these two men were associated with organized crime.... Trump: They were tough guys. In fact, they say that Dan Sullivan was the guy that killed Jimmy Hoffa. I don’t know if you ever heard that. O’Brien: I have heard that. And that he was, you know…
Also,
Trump: I just was able to handle them. And I, really, I was able to handle them. I found Sullivan to be the tougher of the two. I started hearing reports about Sullivan, that he killed Jimmy Hoffa….
Also,
O’Brien: What was Shapiro like? Trump: He was like a third-rate, local, real estate mob guy. Nothing spectacular. And I, you know, I got lucky. I heard a rumor that Sullivan, because Sullivan was a great con man, I heard a rumor that Sullivan killed Jimmy Hoffa. And because I heard that rumor I kept my guard up. You know, I said, 'Hey, I don’t want to be friends with this guy.' So here was Trump connecting Sullivan to the Hoffa murder and calling Shapiro a 'mob guy.'
The same article also asserted that Trump lied in a deposition about knowing and working with Felix Sater, who who "had once been involved in a Mafia-linked stock swindle," and who "had worked with the Trump Organization." Ivanka Trump and Donald Trump Jr Escaped Indictment for Fraud As reported by the New Yorker in October, 2017, despite considerable evidence that the two children of Donald Trump had misled potential buyers of Trump SoHo condominiums, Cyrus Vance, the Manhattan District Attorney overruled his staff by halting an investigation of them in 2010.  Later, the Trumps' attorney, Marc Kasowitz, made a large donation to Mr Vance's campaign.    Trump University Settled Fraud Allegations, Trump Not Charged As reported by the New York Times in 2017, "the final settlement of allegations that 'Trump University students had been cheated out of thousands of dollars in tuition through high-pressure sales techniques and false claims about what they would learn" was approved by a judge. Litigation about these allegations had gone on for years, but after his election in November, Mr. Trump reversed course and agreed to pay $25 million to resolve the litigation. He did not admit fault, and he maintained in posts on Twitter after the settlement announcement that he "did not have the time to go through a long but winning trial on Trump U." The settlement resolved lawsuits brought by the Attorney General of New York, Eric Schneiderman, among others.  However, Mr Trump was never charged with a crime by Mr Schneiderman among others.  There is some reason to think Mr Trump took actions to ensure his impunity. According to Bloomberg on May 11, 2018,
Back in 2013, Donald Trump was exploring a presidential run. His Trump University was in the crosshairs of New York’s crusading attorney general. Around the same time, Trump and his personal lawyer got an interesting piece of information: Eric Schneiderman, the AG, was accused of sexually abusing two women.
The details of the accusations were not made public at that time, but later,
Trump took aim at Schneiderman in a tweet on Sept. 11, 2013, that also referred to New York politicians who’d resigned over allegations of sexual misconduct, Anthony Weiner and Eliot Spitzer. 'Weiner is gone, Spitzer is gone -- next will be lightweight A.G. Eric Schneiderman. Is he a crook? Wait and see, worse than Spitzer or Weiner,' Trump tweeted.
Mr Schneiderman never brought criminal charges against Mr Trump.  Could it be that he was made aware that Trump had information about Schneiderman's sexual behavior that he could use against him? This month, the allegations of his sexual misconduct were finally made public and he then resigned.  The settlement, again absent any charges against Mr Trump, was approved in March, 2017. Summary of Trump's Pre-Presidency Impunity While Trump's firms have had to pay multiple fines for breaking rules and laws, and Trump and the immediate family members who work with him in the Trump Organization were credibly accused of multiple types of wrong-doing, including various apparent crimes, neither Trump nor his family members were ever indicted, or apparently investigated for crimes.  President Trump's Arguments That He Has De Jure Impunity Since he was elected, President Trump and his proxies have asserted he now has de jure impunity that seems to go well beyond the sort of de facto impunity he enjoyed as a wealthy and powerful businessman and celebrity.  Note that none of these statements attempted to deny that he had or would violate laws.  They were all assertions that President Trump is not subject to the rule of law. Examples appear again in order of apparent occurrence. Trump Said He is Not Subject to Laws on Conflicts of Interest.  As reported by CNN in November, 2016:
Donald Trump said on Tuesday that he faces no legal obligation to cut ties with his businesses, even as he described how winning the presidency has made his brand 'hotter' and acknowledged advancing his business interests during a conversation with a British politician. 'The law's totally on my side, the president can't have a conflict of interest,' Trump said in an interview with New York Times editors and writers. Trump said he was surprised by how little was legally required of him. 'In theory I could run my business perfectly and then run the country perfectly. There's never been a case like this,' he said. 'I'd assumed that you'd have to set up some type of trust or whatever and you don’t.'
Yet,
It’s true that federal conflict-of-interest laws exempt the president, and he’ll have the power to change White House ethics rules. But there remains a constitutional ban on accepting payments from foreign governments, as well as anti-corruption laws against bribery and fraud.
Trump Stated His Personal or Family Finances Cannot be Subjects of Investigation In an interview with the New York Times in July, 2017, he responded to a question:
SCHMIDT: Last thing, if Mueller was looking at your finances and your family finances, unrelated to Russia — is that a red line? HABERMAN: Would that be a breach of what his actual charge is? TRUMP: I would say yeah. I would say yes. By the way, I would say, I don’t — I don’t — I mean, it’s possible there’s a condo or something, so, you know, I sell a lot of condo units, and somebody from Russia buys a condo, who knows? I don’t make money from Russia. In fact, I put out a letter saying that I don’t make — from one of the most highly respected law firms, accounting firms. I don’t have buildings in Russia. They said I own buildings in Russia. I don’t. They said I made money from Russia. I don’t. It’s not my thing. I don’t, I don’t do that. Over the years, I’ve looked at maybe doing a deal in Russia, but I never did one. Other than I held the Miss Universe pageant there eight, nine years [crosstalk]. SCHMIDT: But if he was outside that lane, would that mean he’d have to go? [crosstalk] HABERMAN: Would you consider—— TRUMP: No, I think that’s a violation.
A typical interpretation of this rather incoherent response was in The Hill,
President Trump warned special counsel Robert Mueller from investigating his family’s finances beyond the scope of the probe into ties between his administration and Russia in an interview with The New York Times on Wednesday. 'I think that’s a violation. Look, this is about Russia,' Trump told the Times. Trump during the interview said he wasn’t ruling out firing Mueller as special counsel on the probe into Russian meddling in the presidential election. He did not say that he would order the Justice Department to fire Mueller or under what circumstances he would fire him, but he indicated Mueller investigating his family's finances would cross a line.
Trump's Attorney Argued that a President Cannot be Charged with Obstructing Justice An article in Axios from December, 2017, strated
John Dowd, President Trump's outside lawyer, outlined to me a new and highly controversial defense/theory in the Russia probe: A president cannot be guilty of obstruction of justice. The 'President cannot obstruct justice because he is the chief law enforcement officer under [the Constitution's Article II] and has every right to express his view of any case,' Dowd claims.
However, a Washington Post article published on May 18, 2018, stated that Mr Trump's current attorney is not so sure about that,
But apparently [current Trump laywer Rudy] Giuliani disagrees. Trump's own lawyer said Friday that his client is not immune from charges of obstructing justice — which is clearly the most troubling part of special counsel Robert S. Mueller III's investigation for Trump personally. While Trump hasn't been directly linked to potential collusion with Russia, he has taken many actions as president that have caught Mueller's attention and could feasibly be seen as trying to influence the course of the investigation. So whether Trump can technically obstruct justice at all is a key point, and it's one Giuliani just conceded.
Trump's Attorneys Argued He Is Immune from Civil Court Proceedings while President They had argued that he has immunity from lawsuits as President, but as Reuters reported this month,
A New York state judge on Tuesday said U.S. President Donald Trump must face a defamation lawsuit by a woman who accused him of sexually harassing her after she appeared on his former reality TV show. The decision by Justice Jennifer Schecter of the New York state court in Manhattan in favor of California restaurateur Summer Zervos, a former contestant on NBC’s 'The Apprentice,' raises the prospect that Trump might have to answer embarrassing questions in court about his behavior toward women. She rejected Trump’s claim that he was immune from being sued, finding 'absolutely no authority' to dismiss litigation related 'purely to unofficial conduct' solely because he occupied the White House. 'No one is above the law,' the judge wrote.
Trump's Attorney Asserted He Cannot be Forced to Testify in Court As reported by Reuters two days ago, on May 17, 2018, President Trump's current lawyer Rudolf Giuliani:
told Fox News Thursday morning not just that the special counsel cannot indict President Trump but that Mueller’s team cannot even subpoena the president to appear before a grand jury. Giuliani’s theory is that if the president cannot be prosecuted, he cannot be called to testify in an investigation of his conduct. 'We’re pretty comfortable, in the circumstances of this case, they wouldn’t be able to subpoena him personally,' Giuliani said. 'They could probably require documents to be produced. That’s what was required of Nixon. We’ve provided 1.4 million documents. They probably could require you to testify in a civil case, possibly even as a witness in a criminal case, but they can’t require you to testify in what would be your own case.'
However,
I talked Thursday to eight lawyers who’ve been involved in previous probes of U.S. presidents. Every one of them said Giuliani’s theory is incorrect. Some of them had quite strong words. George Conway wrote the Supreme Court briefs for Bill Clinton accuser Paula Jones in the case that led to a unanimous ruling from the justices that the Constitution does not shield presidents from testifying in certain civil suits. He said Giuliani’s assertion that President Trump cannot be subpoenaed is 'drivel.' Lawrence Robbins, who represented White House officials in the Whitewater investigation, said Giuliani’s theory is 'facially preposterous.' Solomon Wisenberg, who worked on the Whitewater probe of Clinton, called the theory 'delusional.'
Summary Unaccountable leadership, particularly leadership with impunity, has been a major feature of modern US health care, and probably explains the continuing bad behavior, including criminally bad behavior and outright corrupt behavior ongoing in US health care organizations. While the US government began to address impunity in the last few years, those efforts have apparently halted during the current Trump regime.  Given President Trump's long record of personal impunity during his career as a wealthy and prominent businessman, and his assertions that as President he is above the law, that should be no surprise. Yet, true health care reform requires well-informed leaders who uphold health care professionals' values, put patient's and the public's health ahead of all other considerations, avoid self-interest and conflicts of interest, are honest and ethical, and surely are not corrupt.  They need to work in the context of a government that is of, by and for the people, not of, by and for a demagogic leader. In these times, true health reform is not possible under the current president. We will watch health care dysfunction continue to grow, and patients' and the public's health continue to decline until someone new takes the oath of office.    Article source:Health Care Renewal
0 notes
zoidresearch · 7 years ago
Text
Stocks That Are In News In Share Market
Tumblr media
Here are top stocks that are in news today:
Results today: Vedanta, Power Grid Corporation of India, Glenmark Pharmaceuticals, Ujjivan Financial Services, HEG, Orient Cement, D-Link (India), Sundram Fasteners, Deepak Fertilizers, JSW Holdings, Berger Paints, TCI Developers, Gujarat Pipavav Port, Jay Bharat Maruti, R Systems International, Accelya Kale Solutions, Royal Orchid Hotels, Aspinwall and Company, KSB Pumps, Excel Crop Care, Sanco Industries, Ramco Industries, Andhra Bank, Taj GVK Hotels, Ramco Cements, Dalmia Bharat Sugar, ICRA, Shanthi Gears, Cera Sanitaryware, GE T&D India, Natco Pharma, Akzo Nobel India, Bharat Road Network, Edelweiss Housing Finance, CCL Products, Himadri Speciality Chemical, Peninsula Land, Hindustan Construction Company, Transport Corporation of India, Hathway Cable & Datacom, Shriram City Union Finance, Dhunseri Petrochem
Hero Moto Q2 Net Profit At `1,010.5 Cr Vs CNBC-TV18 Poll Of `1,035 Cr EBITDA At `1,455.7 Cr Vs CNBC-TV18 Poll Of `1,444 Cr EBITDA Margin At 17.4% vs CNBC-TV18 Poll Of 16.6% PAT (GU)0.6% At `1,010.5 Cr Vs `1,004.2 Cr (YoY) Revenue (GU)7.3% At `8,362 Cr Vs `7,796.2 Cr (YoY) EBITDA (GU)6.3% At `1,455.7 Cr Vs `1,368.9 Cr (YoY) EBITDA Margin At 17.4% Vs 17.6% (YoY)
Max India Q2 Net Profit At `2.1 Cr Vs `2 Cr (YoY) Revenue At `16.8 Cr Vs `17.7 Cr (YoY)
Apollo Tyres Q2 Net Profit At `140.2 Cr Vs CNBC-TV18 Poll Of `188.5 Cr Revenue (GU)13% At `3,476.7 Cr Vs `3,085 Cr (YoY) EBITDA (RD)16.9% At `364 Cr Vs `438.7 Cr (YoY) EBITDA Margin At 10.48% Vs 13.24% (YoY) Net Profit At `140.2 Cr Vs `259.5 Cr (YoY)
Hexaware Q3 Net Profit At `142.3 Cr Vs CNBC-TV18 Poll Of `118.9 Cr ` Revenue (GU)1% At `993.1 Cr Vs `983.6 Cr (QoQ) $ Revenue At $154 m Vs CNBC-TV18 Poll Of $153.7 m EBITDA (GU)8.4% At `173.7 Cr Vs `160.2 Cr (QoQ) EBITDA Margin At 17.49% Vs 16.29% (QoQ) Net Profit (GU)16% At `142.3 Cr Vs `122.4 Cr (QoQ) $ Revenue (GU)0.9% Vs CNBC-TV18 Poll Of 0.7% Growth
Tech Mahindra Q2 Net Profit At `836 Cr Vs CNBC-TV18 Poll Of `740 Cr ` Revenue At `7,606 Cr Vs CNBC-TV18 Poll Of `7,551 Cr $ Revenue At $1,179.2 m Vs CNBC-TV18 Poll Of $1,173 m $ Revenue Up 3.6% Vs CNBC-TV18 Poll Of 3% Growth EBIT At `840 Cr Vs CNBC-TV18 Poll Of `793 Cr EBIT Margin At 11% Vs CNBC-TV18 Poll Of 10.5%
Net Profit (GU)4.7% At `836 Cr Vs `798.6 Cr (QoQ) $ Revenue (GU)3.6% At $1,179.2 m Vs $1,138.1 m (QoQ) ` Revenue (GU)3.7% At `7,606 Cr Vs `7,336.1 Cr (QoQ) EBIT (GU)22.2% At `840 Cr Vs `688 Cr (QoQ) EBIT Margin At 11% Vs 9.4% (QoQ) Other Income At `322.2 Cr Vs `410.7 Cr (QoQ)
Forex Gain At `227 Cr Vs `272.6 Cr (QoQ) Attrition Rate (LTN) At 16% Vs 17% (QoQ) IT Utilisation At 81% Vs 77% (QoQ) IT Utilisation (Excluding Trainees) Unchanged At 81% QoQ
Mahindra Holidays Q2FY18 YoY Revenue down 6% at 243cr EBITDA down 12% at 54.1cr Margins at down 150 bps at 22.3% PAT down 3% at 31.7cr
Music Broadcast Q2FY18 YoY Post IPO blues, Other expenses up 46% Revenue up 10% at 75.8cr EBITDA down 16% at 24.1cr Margins down 980 bps at 31.8% PAT down 11% at 12.7cr
Camlin Fine Q2FY18 YoY Revenue up 26% at 144.2cr EBITDA down 76% at 4.5cr Margins at 3.1% vs 16.2% Loss at 3.3cr vs PAT of 0.76 cr
Apar Industries Q2FY18 YoY Revenue down 3% at 1247cr EBITDA down 12% at 87.7cr Margins down 70 bps at 7% PAT down 43% at 26cr
TCI Express Q2FY18 YoY Revenue up 10% at 203cr EBITDA up 14% at 19.1cr Margins up 40 bps at 9.4% PAT up 36% at 13.5cr
ABC bearings Q2FY18 YoY Revenue up 9% at 46.6cr EBITDA up 3% at 6.7cr Margins down 80 bps at 14.4% PAT up 49% at 2.09cr
ENIL Q2FY18 YoY Revenue down 3% at 125.7cr EBITDA up 23% at 28.3cr Margins up 480 bps at 22.5% PAT down 25% at 6cr Higher tax expense leads to lower PAT
Hikal Q2FY18 YoY Revenue up 26% at 292cr EBITDA up 15% at 53.4cr Margins down 170bps at 18.3% PAT down 6% at 15.3cr
Eclerx Q2FY18 YoY Rise in expenses leads to margin contraction Revenue down 1% at 330cr EBITDA down 25% at 96cr Margins down 910 bps at 29.1% PAT down 9% at 8.8cr
Cognizant Q3 Revenue At $3.77 Bn Vs $3.67 Bn (QoQ) Net Profit At $495 m Vs $470 m (QoQ)
Subros Q2 Net Profit At `15.1 Cr Vs `4.9 Cr (YoY) Revenue At `497.2 Cr Vs `432.9 Cr (YoY)
TFCI Q2 Net Profit At `19.2 Cr Vs `16.4 Cr (YoY) Revenue At `53.9 Cr Vs `50.3 Cr (YoY ONGC Says Citibank, SBI Cap Appointed As Transaction Advisor For HPCL Deal DIPAM Has Appointed JM Financial As Transaction Advisor For ONGC-HPCL Deal
Aurobindo Pharma Gets US FDA Nod For Fexofenadine & Pseudoephedrine Hcl Tablets Fexofenadine Is Used For Treatment Of Allergy Symptoms Such As Hay Fever Pseudoephedrine Is Used As A Nasal/Sinus Decongestant
October Auto Sales: Tata Motors Total JLR US Sales (RD)4.4% At 8,368 Units Vs 8,751 Units (YoY) Total Jaguar US Sales (RD)10.2% At 2,891 Units Vs 3,219 Units (YoY) Total Land Rover US Sales (RD)1% At 5,477 Units Vs 5,532 Units (YoY) Get Sensex, Nifty market trading calls by experts. Recover your loss in share market with best stock tips, click here https://goo.gl/9A28mr
0 notes